Table 3.
Adjusted OR (95% CI) for scores on CERAD, AFT, and DSST tests across quartile of total VB2 intake
| Variables | OR1 | 95% CI1 | P1 |
|---|---|---|---|
| CERAD Delayed Recall | |||
| Q2 vs Q1 | 1.30 | 0.88, 1.91 | 0.177 |
| Q3 vs Q1 | 1.23 | 0.90, 1.69 | 0.183 |
| Q4 vs Q1 | 1.39 | 1.00, 1.92 | 0.048 |
| CERAD Trial 1 Recall | |||
| Q2 vs Q1 | 1.30 | 1.01, 1.68 | 0.042 |
| Q3 vs Q1 | 1.32 | 1.10, 1.60 | 0.005 |
| Q4 vs Q1 | 1.38 | 1.09, 1.75 | 0.011 |
| CERAD Trial 2 Recall | |||
| Q2 vs Q1 | 1.20 | 0.91, 1.59 | 0.175 |
| Q3 vs Q1 | 1.08 | 0.83, 1.42 | 0.538 |
| Q4 vs Q1 | 1.50 | 1.09, 2.06 | 0.015 |
| CERAD Trial 3 Recall | |||
| Q2 vs Q1 | 1.14 | 0.87, 1.49 | 0.331 |
| Q3 vs Q1 | 1.19 | 1.00, 1.43 | 0.049 |
| Q4 vs Q1 | 1.15 | 0.88, 1.50 | 0.279 |
| CERAD total | |||
| Q2 vs Q1 | 1.78 | 0.87, 3.67 | 0.110 |
| Q3 vs Q1 | 1.71 | 1.02, 2.87 | 0.043 |
| Q4 vs Q1 | 2.38 | 1.22, 4.63 | 0.014 |
| AFT | |||
| Q2 vs Q1 | 1.01 | 0.54, 1.89 | 0.981 |
| Q3 vs Q1 | 2.19 | 1.07, 4.46 | 0.033 |
| Q4 vs Q1 | 2.79 | 1.19, 6.51 | 0.021 |
| DSST | |||
| Q2 vs Q1 | 1.85 | 0.29, 11.9 | 0.495 |
| Q3 vs Q1 | 7.35 | 1.21, 44.6 | 0.032 |
| Q4 vs Q1 | 45.1 | 3.99, 510 | 0.004 |
1adjusted for age, gender, race, PIR, BMI, alcohol intake, and smoking status